Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,886.24
(
1.02%
)
US TECH 100
24,781.60
(
0.35%
)
Dow Jones
48,218.25
(
0.63%
)
Brent Oil
96.00
(
0.56%
)
Bitcoin
74,556.14
(
0.08%
)
News Focus
News Focus

Replies to post #124 on TC BioPharm Holdings Plc (TCBP)

Replies to #124 on TC BioPharm Holdings Plc (TCBP)
icon url

Cameo Brien

03/17/22 7:26 AM

#125 RE: Anita Dump #124

Good info
icon url

Cameo Brien

03/17/22 7:39 AM

#126 RE: Anita Dump #124

Good info ty
icon url

resx18

03/17/22 7:50 AM

#127 RE: Anita Dump #124

Complete and near complete responses (morphologic leukemia-free state) observed with OmnImmune® starting at lowest dose level in Phase 1b/2a study for the treatment of relapsed/refractory acute myeloid leukemia